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Summary 
Experimental analyses of the acute cytotoxic T  lymphocyte (CTL) response to viruses have fo- 
cused on studying these infections in immunologically naive hosts. In the natural environment, 
however, viral CTL responses occur in hosts that are already immune to other infectious agents. 
To address which factors contribute to the maintenance and waning of immunological memory, 
the following study examined the frequencies of virus-specific CTL precursor cells (pCTL) not 
only using the usual experimental paradigm where mice undergo acute infections with a single 
virus, and in mice immune to a single virus, but also in immune mice after challenge with various 
heterologous viruses. As determined by limiting dilution assays, the pCTL frequency (p/f) per 
CD8 + T  cell specific for lymphocytic choriomeningitis virus (LCMV), Pichinde virus (PV), or 
vaccinia virus (VV) increased during the acute infections, peaking at days 7-8 with frequencies 
as high as 1/27-1/74.  Acute viral infections such as these elicit major expansions in the CD8 + 
T  cell number, which has been reported to undergo apoptosis and decline after most of the viral 
antigen has been cleared. Although the decline in the total number of virus-specific pCTL after 
their peak in the acute infection was substantial, for all three viruses the virus-specific p/f per 
CD8 + T  cell decreased only two- to fourfold and remained at these high levels with little fluc- 
tuation for well over a year. The ratios of the three immunodominant peptide-specific to total 
LCMV-specific clones remained unchanged between days 7 and 8 of acute infection and long-term 
memory, suggesting that the apoptotic events did not discriminate on the basis of T  cell recep- 
tor specificity, but instead nonspecifically eliminated a large proportion of the activated T  cells. 
However, when one to five heterologous viruses  (LCMV, PV, VV, murine cytomegalovirus, and 
vesicular stomatitis virus) were sequentially introduced into this otherwise stable memory pool, 
the stability of the memory pool was disrupted.  With each successive infection, after the immune 
system had returned to homeostasis, the memory p/f specific to viruses from earlier infections 
declined. Reductions in memory p/f were observed in all tested immunological compartments 
(spleen, peripheral blood, lymph nodes, and peritoneal cavity), and on average in the spleen re- 
vealed a 3  +  0.4-fold decrease in p/f after one additional viral infection and an 8.4  -+ 3-fold 
decrease after two additional viral infections.  Thus,  subsequent  challenges with heterologous 
antigens, which themselves induce memory CTL, may contribute to the waning of CTL mem- 
ory pool to earlier viruses as the immune system accommodates ever-increasing numbers of new 
memory cells within a limited lymphoid population. This demonstrates that virus infections do 
not occur in immunological isolation,  and that CD8 §  T  cell responses are continually being 
modulated by other infectious agents. 
M 
emory CD8 §  percursor  CTL  (pCTL)  1 specific for 
.viruses proliferate  and  can  be  maintained  for pro- 
longed time periods in vivo in the absence of detectable viral 
antigens (1-5), but factors contributing to the maintenance 
and modulation of CTL memory have remained undefined. 
Acute infections of mice with lymphocytic choriomeningi- 
tis virus (LCMV), Pichinde virus (PV), vaccinia virus (VV), 
and murine  cytomegalovirus (MCMV)  can lead to  5-20- 
1Abbreviations used in this paper: GP, glycoprotein; LCMV, lymphocytic 
choriomeningitis virus; LDA, limiting  dilution assay; MCMV, murine cy- 
tomegalovirus; NP, nucleoprotein; pCTL, precursor CTL; PEC, perito- 
neal exudate cell; p/f, pCTL frequency; PV, Pichinde virus; VSV, vesicu- 
lar stomatitis virus; VV, vaccinia virus. 
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between days 6 and 9 after infection (6, 7, and our unpub- 
lished data). Thereafter, the T  cell number declines, bring- 
ing about homeostasis in lymphocyte numbers  (7-13) after 
most of the viral antigen has been cleared (7, 12,  13). In the 
case of LCMV, this decline in lymphocyte number is asso- 
ciated  with  enhanced  susceptibility of isolated T  cells  to 
apoptosis in vitro (7, 8, 12,  13) and with high levels ofapop- 
tosis  in  the  spleen  T  cell  populations  in  vivo  (11).  The 
memory T  cell population must therefore consist ofpCTL 
that survive these apoptotic events. In the present study we 
examine, by limiting dilution assays (LDAs), the virus-spe- 
cific pCTL frequency (p/t) to LCMV,  PV,  and VV before 
and after these apoptotic events and find that, even though 
there are large reductions in the total number ofpCTL, the 
CTL  p/f per CD8 §  T  cell remains remarkably high  after 
the apoptotic events have occurred and after detectable an- 
tigen has been  cleared.  The  CTL  p/f specific to  LCMV, 
PV,  or  VV  and  to  three  LCMV-immunodominant  pep- 
tides remain unchanged for well over a year, illustrating the 
remarkable stability in T  cell memory. 
Our  previous  studies,  however,  have  shown  that  im- 
mune responses to viral infections are not mounted in im- 
munological isolation, as the immune response to one virus 
may condition a host to make an altered response to a sec- 
ond unrelated or heterologous virus by reactivation of the 
memory CTL specific to the first virus (14,  15). This reac- 
tivation of memory CTL to an earlier virus is due at least in 
part to the ability of memory CTL to recognize in a cross- 
reactive manner heterologous viruses. There appears to be 
sufficient diversity within the memory pCTL repertoire spe- 
cific for one virus to render some clones susceptible to acti- 
vation  by  apparently  unrelated  heterologous  viruses.  En- 
hanced expression of adhesion molecules (6) and IL-21< (5, 
16)  on memory cells might make them particularly sensitive 
to stimulation by a low affinity, cross-reactive T  cell anti- 
gen. This reactivation of memory CTL by heterologous vi- 
ruses can prime the CTL response to challenge virus and play 
a role in either immunity (17) or immunopathology (18). 
Given the  nature  of the  activation of memory  cells by 
heterologous viruses, we questioned whether such heterol- 
ogous virus infections would impart a more lasting or ret- 
rospective effect on the memory CTL response to previous 
infectious agents.  Here  we  demonstrate  that  heterologous 
viral infections disrupt the homeostasis of stable long-term 
CTL memory by causing reductions in the CTL p/f specific 
for viruses to which the host has previously been exposed. 
Materials  and Methods 
Mice,  C57BL/6  (H-2  b) male mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME) and used at 2-24 mo of age. 
Viruses.  The  LCMV  Armstrong  strain  was  propagated  in 
BHK21 baby hamster kidney cells (19). The WR strain of  VV (14) 
and the AN3739 strain of PV, an arenavirus only distantly related 
to LCMV, were propagated in L929 cells (14, 20). MCMV, strain 
Smith,  was  obtained  from  salivary glands  of in  vivo-infected 
BALB/c mice (21).  Vesicular stomatitis virus (VSV), strain Indi- 
ana, was propagated in BHK21  cells.  For acute virus infections, 
mice  were  injected  intraperitoneally with  4  ￿  104  PFU  of 
LCMV, 8  ￿  106 or 1.5  ￿  107 PFU of VV,  106 PFU of PV,  105 
PFU of MCMV, or 9 ￿  108 PFU of VSV in 0.1-0.3-ml volume. 
Cell Lines.  KO (H-2b), an SV40-transformed kidney cell line 
derived from a C57BL/6 mouse (22) and provided to us by Dr. 
Satvir Tevethia (Pennsylvania  State Medical Center, Hershey, PA) 
was  propagated in DMEM  (GIBCO  BR.L,  Gaithersburg,  MD) 
supplemented with 100 U/ml penicillin G, 100 p~g/ml streptomy- 
cin  sulfate,  2  mM  L-glutamine,  5  X  10 -s  M  2-ME,  10  mM 
Hepes, and 10% heat-inactivated (56~  30 rain) fetal bovine serum 
(FBS; Sigma Chemical Co., St. Louis, MO). L929 (H-2k), a con- 
tinuous liver cell line derived from C3H mice, was propagated in 
Eagle's MEM (GIBCO B1KL) supplemented with 100 U/m] pen- 
icillin G,  100  I.tg/ml streptomycin sulfate,  2  mM  L-glutamine, 
and  10%  heat-inactivated  FBS.  KO  cells  were  infected  with 
LCMV or PV at a multiplicity of infection (MOI) of 0.1-0.2 PFU/ 
cell and incubated for 2 d at 37~  KO cells were infected with 
VV at a MOI of 4 for 3-4 h at 37~ 
Responder Cells.  Adult C57BL/6 mice were inoculated intra- 
peritoneally with the indicated viruses, and at the indicated times 
after infection spleens, LNs, peritoneal exudate cells (PECs), and 
peripheral blood leukocytes were harvested. The LN cells were 
derived from a pool of the bilateral axillary and inguinal LNs in 
each mouse. The LCMV-, PV-, and VV-specific p/f per CD8 + 
were quantified by LDAs of unsorted ceils (15, 23). The percent- 
age  of CD8 +  T  cells  was  determined by  fluorescent  antibody 
staining and analyzed on either a FACS  |  440 (Becton Dickinson, 
San Jose,  CA)  or FACStar  |  Plus  (Becton Dickinson), as previ- 
ously described (15, 23). 
Infection Protocol with Heterologous Viruses.  Mice were  immunized 
with a sublethal dose of one virus. After the rise  and fall of the 
acute T  cell response and when the immune system had returned 
to homeostasis (usually 5 wk or longer), the mouse was  inocu- 
lated with another virus. After the T  cell response to the second 
virus returned to homeostasis, the animals were tested for pCTL 
specific for each virus. Subsequent infections with additional vi- 
ruses were also tested. To strengthen the significance of the ob- 
servations, the experimental design was set up to examine in one 
mouse the p/f simultaneously to two or three viruses within dif- 
ferent  memory  cell compartments.  For example,  the  LCMV-, 
PV-, and W-specific p/f in the spleen, LNs, and/or PECs were 
assessed at the same time in the same mouse  that had received 
LCMV+PV+VV+MCMV  and  compared  with  appropriate 
controls to determine the effect of subsequent virus infections on 
CTL responses to all three viruses. 
The interassay variability for p/f may vary 2-10-fold and is de- 
pendent on prevailing culture conditions, such as the lot of FBS 
or cytokine supernatant that is used. Generally, we had very re- 
producible results between assays, as can be seen in Fig. 1; these 
memory p/f were done in separate experiments but all within a 
close time period with very similar culture conditions. Except for 
Fig. 1, all the data presented comparing changes in p/f were gen- 
erated within the same LDA experiments. With our LDA proto- 
col,  six  separate  titrations  of the  spleen  cells  from  the  same 
LCMV-immune mouse within one LDA set up had a mean p/f 
per CD8 + T  cell of 1/28  _+  2.2  (SEM;  range:  1/21-1/36).  No 
technically acceptable assays examining the deletion of spleen p/f 
by subsequent virus infections were deleted from these tables, i.e., 
there was  no  author-imposed selectivity in  the  presentation  of 
these data. 
LDAfor  Virus-specificpCTL.  The assays used the procedure of 
Moskophidis et al. (24) with modifications as previously described 
2490  Reduction of CTL Memory by Heterologous Viruses (15, 23). Briefly, for LCMV and PV assays, splenic lymphocytes from 
infected mice (one mouse or two pooled) were harvested and ti- 
trated  in  U-96-well plates  with  24  replicates  at  each  titration. 
They were stimulated with virus-infected PECs (3-4 ￿  104/well), 
supplemented  with  irradiated  splenic  feeders  (1-2  ￿  105/well) 
and growth factors provided by using a  16% culture supematant 
from IL-2-secreting, gibbon lymphoma tumor cell line MLA.144 
(American Type Culture Collection, Rockville, MD)  (25).  After 
4 d, the cultures were fed with 104 irradiated, virus-infected PECs. 
The  highly lytic nature  of VV in vitro required the use of a 
slightly altered method. PECs infected with VV (3-4 ￿  104 cells/ 
well) in vivo were used as stimulators, and neutralizing polyclonal 
rabbit antiserum  to VV was added at a  1/100 dilution final con- 
centration (15, 26). 
On days 7-8 of culture, individual wells were split twofold and 
assayed for cytolytic function on infected or peptide-coated tar- 
gets and uninfected syngeneic target cells (KO) using a modified 
SlCr-release assay. SlCr-labeled targets (5 X  103) were added to all 
wells. The plates were incubated 8-10 h at 37~  in a 5% CO  2 in- 
cubator,  centrifuged for 5  min at  130 g  (CRU-5000  centrifuge, 
International Equipment  Co.,  Needham  Heights, MA),  and  the 
supernatant  was harvested. Radioactivity released into the super- 
natant  was  counted  on  a  gamma  counter  (Clinigamma  model 
1272;  LKB,  Gaithersburg,  MD).  Positive  wells were  defined as 
those  wells whose  SlCr-release  exceeded the  mean  spontaneous 
release by >3  SD. All wells that lysed uninfected syngeneic tar- 
gets were eliminated from the analysis.  Frequencies were  calcu- 
lated  using  chi  squared  analysis  according to  TasweU  (27)  on  a 
computer program kindly provided by Dr. Richard Miller (Uni- 
versity of Michigan, Ann Arbor, MI). 
Peptide-coated Targets.  KO cells were incubated overnight with 
100-200  DM of indicated  peptide.  The  LCMV  H-2b-restricted 
immunodominant peptides, nucleoprotein (NP)397  (QPQNGQ- 
FIHFY), glycoproteins (GP)34 (AVYNFATCG) and GP278 (VEN- 
PGGYCL), were synthesized by Dr. Robert Carraway (University 
of Massachusetts  Medical Center).  These peptides were purified 
to  >95%  homogeneity by reverse-phase HPLC.  The high con- 
centrations  of peptides  used  were selected after peptide  titration 
studies  and  were  chosen  to  enhance  the  efficiency in detecting 
pCTL  in LDAs, where  the low numbers  of effectors present in 
each well are further split into two wells for the cytotoxicity as- 
says.  Furthermore,  KO  target  cells were  found  to  express  rela- 
tively low levels of class I MHC antigens.  These assays remained 
quite specific, as PV-induced  CTL did not lyse KO cells coated 
with any of the LCMV peptides. 
Statistical Analyses.  Spearman's correlation coefficient and the 
one-sample t test were used for data analysis  where appropriate. 
Results 
Stability  of Long-term CTL Memory  after Acute  Viral Infec- 
tions.  During the early stages of infection,  the virus-spe- 
cific CTL p/f per splenic CD8 + T  cell  increased, peaking 
at 1/31,  1/27,  and 1/74 for LCMV,  PV,  and VV, respec- 
tively, on days 7-8  (Fig.  1, A-C). Under these conditions, 
infectious virus was cleared from the spleen by day 7, with no 
evidence  of long-term persistence  of these viruses  (1,  18, 
28). Analysis of p/f subsequent to the peak of the T  cell re- 
sponse  and  the  ensuing  apoptosis  events  surprisingly  re- 
vealed that,  although freshly isolated T  cells  were not di- 
rectly cytotoxic to virus-infected targets, the p/f per CD8 + 
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Figure  I.  Stability of long-term CTL memory after acute  viral infec- 
tions. Adult C57BL/6 (H-2  b) mice were inoculated intraperitoneally with 
LCMV, PV, or W.  At indicated  times after infection,  the LCMV- (A), 
PV- (B), and W-specific (C) p/f per CD8 + was quantified by LDAs of 
unsorted  splenocytes. The virus-specific p/f per CD8  + cell are displayed 
above the pCTL/50,000 CD8  + splenocytes plotted.  For LCMV, the data 
from days 0 to 8 are averages of two to four experiments  at each  time 
point.  For PV and VV, the data from days 0 to 8 represent one single ex- 
periment with all time points tested in the same LDA, including  one im- 
mune mouse time point.  The pCTL from immune mice (>6 wk) for all 
three viruses were derived from separate experiments.  (*)The same stock 
and input titers of virus were used for all of the LCMV and PV experi- 
ments.  The 202- and  437-d samples in the VV experiment were from 
mice receiving 8 X  106 PFU of one virus stock and the rest of the time 
points were from mice receiving 1.5 ￿  107 PFU of a second stock. 
splenic  T  cell was  only two-  to  fourfold less  in  immune 
mice  than  it was  at  the  peak of the  acute  CTL response 
(Fig.  1, A-C). Thereafter the p/f remained remarkably sta- 
ble for LCMV and PV,  even out to  14-27  mo (Fig.  1, A 
and B).  The p/f also  appeared very stable for VV, though 
the data for 202 and 437 d after infection shown in Fig. 1 C 
were generated from a different virus input stock receiving 
half the virus dose of that in the rest of the figure. 
This rather small drop in p/f per CD8 + T  cell between 
the acute and memory T  cell response has not been appre- 
ciated before (1, 6, 7,  13,  29), but it is consistent with pre- 
viously reported data for LCMV showing a greater drop in 
p/f per  splenocyte  if it  were  corrected for  CD8 +  T  ceil 
number (1).  The apparent greater drop per splenocyte is a 
consequence  of a  significant  drop  in  the  percentage  of 
2491  Selin et al. CD8 + T  c~lls per spleen ( LCMV day 8 CD8: 38% --- 4 vs. 
LCMV-immune CD8:  13% --+ 0.6, n  =  3), as well as a ma- 
jor reduction in the total number of splenocytes (6,  7,  13). 
In  three  experiments  there  were  on  average  1.5  )<  106 
pCTL/spleen on day 8 vs. 2.2 X  10S/spleen in the immune 
state,  or about a sevenfold reduction in total pCTL number. 
Stability of the LCMV-immunodominant,  Peptide-spedfic CTL 
p/f.  Sinular stabilities in p/f per CD8 + T  cell were found 
not only in  the  quantitative  but also in  the  qualitative  na- 
ture  of the  CTL  response.  The  p/f per  CD8 +  T  cell  for 
each  of three  H-2Lrestricted,  LCMV-immunodominant 
peptides was, like the total LCMV-specific pCTL, reduced 
about  twofold between  day 8  and immune,  and  the  ratios 
ofpeptide-specific to total LCMV-specific clones were un- 
changed  (Table  1).  These  unchanged  specificities  in  the 
CD8 + T  cell populations suggest that after infectious virus 
has been cleared, the apoptotic downregulation in CD8 + T 
cell  number  occurs  across-the-board  among the  activated 
lymphocytes and is apparently not influenced by the speci- 
ficity of the  TCR.  This argues  that  there  is little  selective 
elimination  or protection of the  virus-specific T  cells  dur- 
ing this phase of memory cell development. 
Stability  of LCMV-induced,  Allospecific CTL  Repertoire. 
We have previously shown that LCMV induces allospecific 
as well  as  virus-specific CTL activity; clonal  analyses have 
shown that individual clones propagated on LCMV-infected 
syngeneic APCs may lyse both  a  virus-infected  syngeneic 
target and an uninfected H-2  k allogeneic target, or, surpris- 
ingly, lyse the  allogeneic  target  but  not  the  virus-infected 
target (23). We examined an additional indicator of the sta- 
Table  1.  Stability of the LCMV-spedfic and Viral Peptide-specific 
p/failer Ds 7-8 of LCMV Infection 
Ds 7-8 
pCTL per  (pCTL/50,000 
CD8 + cells*  CD8 + cells)  LCMV immune* 
LCMV-specific  2,133 -  305 (5)~  1,230  --- 264 (7) 
(1/25)11  (1/51) 
GP278-specific￿82  628  -+ 69 (3)  424 •  107 (3) 
(1/82)  (1/142) 
GP278/LCMV ratio  0.31  0.35 
GP34-specific￿82  1,054  -+ 83 (3)  662 +- 170 (3) 
(1/48)  (1/91) 
GP34/LCMV ratio  0.53  0.55 
NP-specific￿82  349  --- 141 (2)  196 ___ 42 (4) 
(1/171)  (1/294) 
NP/LCMV ratio  0.15  0.17 
*LCMV- and peptide-specific p/f per (21)8 ~ cell were quantified as 
described in Materials and Methods. 
tLCMV-irnrnune refers to mice >6 wk after infection. 
Number of experiments. 
lip/f per C1)8 ~ cell. 
'IL('MV I-l-2h-restricted immunodominant peptides are NP397, GP34, 
and GP278. 
bility of  the specificity of the CTL repertoire during the con- 
version of the acute response to the memory response,  the 
p/f of H-2V'---specific CTL propagated  on  LCMV-infected 
APCs. A study of 114 LCMV-specific CTL clones derived 
at  day  8  after  infection,  and  of  114  CTL  clones  from 
LCMV-immune mice,  revealed an identical  10% (11/114) 
that  cross-reacted  with  H-2  k,  as  demonstrated  by the  lysis 
of L-929 cells.  An additional  11% (14/128)  of day 8 clones 
and  14% (18/132)  of immune clones propagated on LCMV- 
infected  syngeneic  APCs  lysed  allogeneic  (L-929)  targets 
without lysing virus-infected syngeneic targets.  These  ob- 
servations  add  further  support  to  the  hypothesis  that  the 
relative specificity of the LCMV-induced T  cell repertoire 
does not change between day 8 and long-term memory. 
Reduction in  Virus-specie  CTL p/f afier Heterologous Virus 
Infections.  Although the frequency of virus-specific mem- 
ory CTL remained remarkably stable over a period of many 
months (Fig.  1), infections with other viruses disrupted this 
homeostasis.  Below are shown a series of experiments  de- 
signed  to determine  whether  heterologous viral  infections 
would  positively  or  negatively  influence  immunological 
memory to  earlier  viruses.  The  strategy was  to  immunize 
mice with a sublethal acute infection of one virus, allow for 
the rise and fall of the T  cell response with a return  to ho- 
meostasis,  and then inoculate with another virus.  After the 
T  cell  response  to  that  second  infection  returned  to  ho- 
meostasis,  the  animals  were  tested  for  pCTL  specific  for 
each  virus.  Subsequent  infections  with  additional  viruses 
were  also  tested.  Fig.  2  A  is  a  representative  experiment 
from  a  single  L1)A  demonstrating  a  2.5-fold  decrease  in 
LCMV-specific splenic p/f per CD8 ~ T  cell after a subse- 
quent PV infection and a 16-fold decrease after a third virus, 
MCMV  (Fig. 3 A). Pig. 2  B, done at the same time as Fig. 
2 A, demonstrates in the same LCMV+PV immune mouse 
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Figure 2.  Reduction ofLCMV- (A) and PV-specific (13) memory CTI. 
p/f per (21)8" spleen cells aSer subsequent heterologous virus infections. 
Quantification by LDA was made of LCMV- (A) and  PV-specific (/3) 
splenic CTL p/f per CI)8' T cell m C57BL/6 mice. These mice were 
immunized with a sublethal acute inl;zction of LCMV, the T cell response 
was allowed to rise and return to homeostasis (>6 wk after infection), and 
then PV was given, followed by M('MV, allowing each time for a return 
to homeostasis before giving the next virus or testing for CTL p/f 
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Figure 3.  Deletion ofLCMV- (A) and PV-specific (B) memory CTL in different memory compartments by heterologous viral infections and boosting 
of LCMV-specifie memory CTL by reinfection of these mice with LCMV. LCMV- or PV-specific splenic (hatched bar, A  and B: Exp,  I-4), LN (right di- 
agonal striped bar, A  and B: Exp.  I and 2), peripheral blood (vertical striped bar) (A, Ex  T. 2), and PEC (solid bar< A  and B: Exp. 3 and 4) pCTL/50,O00 CD8 + 
cells  were quantified by LI)A as previously described. The same individual mouse was used to derive the data for the different memory compartments 
within each experiment. The same mouse used to derive the PV-specific p/fin Exp. 1-3 was used to derive the LCMV-specific p/f. These experiments 
were carried out in clean, pathogen-flee environments. HoWever, for more strict pathogen-flee conditions, some experiments were done in mice housed 
in microisolator cages (Fig. 3 B, Exp. 4). The bracketed numbers over each bar represent the fold change in pCTL/50,000 CD8 + T  cells in mice after re- 
ceiving the indicated heterologous virus infections in comparison to the control, which did not receive any more subsequent infections. 
that, as the decrease in LCMV-specific p/f is occurring after 
a  subsequent  MCMV  infection,  there  is  a  simultaneous 
fourfold  decrease  in  PV-specific  p/f after  a  subsequent 
MCMV infection. Fig. 2 B also shows that a prior infection 
with LCMV does not si~nificandy alter the PV-spe~ific p/f. 
Not only was there a red~etion in ~r pCTL/CD8 cell caused 
by subsequ~rtt  infections, but the total number of pCTL aL~o 
decreased.  The  total  numbers  of LCMV-specific  pCTL/ 
spleen  in  Fig.  2 A  were the  following: LCMV--274,914; 
LCMV+PV--58,173;  and LCMV+PV+MCMV--12,030. 
The total numbers  of PV-specific pCTL/spleen were the 
following:  PV--173,502;  LCMV+PV~184,843;  and 
LCMV+ PV+MCMV--54,032. 
Tables 2-4 are a composite of eight experiments demon- 
strating  27  comparisons  in, which  mice  receiving various 
sequential  infections with  LCMV,  PV,  W,  MCMV,  and 
VSV were tested for CTL specific to LCMV, PV, or VV, 
respectively.  All  paired  oknervations  were  done  at  the 
same time in thr  sama LDA, and, each experiment number 
throughout the three table~ represents LDAs run on a single 
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day as parts of the same experiment. Table 2 i demonstrates 
the expected result that, when an LCMV-immune mouse 
was reinfected with LCMV instead ofa heterologous virus, 
there was a dramatic increase in p/f per CD8 + spleen cell or 
PEC.  irl  virvaaUy every case,  however, ~ubsrqurrrt infec- 
tions of immune mice with heterologom viruses roduced the 
frequency of memory pCTL specific to vila/ses from earlier 
infections.  In  mice  initially  infected  with  LCMV  there 
were means of 2- (+ 0,3, SEM; n '" 3), 3~ (--2 0..5, n =  3), 
and  3.9-fold  (•  0.3;  n  =  2)  decreases in p'/f per  CD8 + 
spleen  cell after infections with  PV,  PV+VV,  and  PV+ 
VV+MCMV,  respectively (Table 2,  ii,  iii,  and  iv).  This 
gradual decrease in LCMV-specific p/f with increasing num- 
bers ofsubsequerrt heterologom infections (LCMVaeW+ 
VV+MCMV)  was  significant,  as  determined  by  Spent- 
man's correlation coe~cient (P ~  0,016),  In one exl:mn~ 
merit in which MCMV was given a~ the thit*d virus instead 
of VV,  a  more  profound  16-fold  decrease was  obsorved 
(Table 2 iii, Fig. 2 A). Some regtoration of .LCMV-specifia 
pCTL was noted after rechallenge with LCMV (Table 2 v). Table 2.  Reduction  in LCMV-specific pCTL/50,O00  CD8 + T  Cells after Heterologous  Virus Infections 
LCMV-specific pCTL/50,000  CD8 + T  Cells* 
Exp. No.*  Control  Test  Fold change 
i) Rechallenge with Homologous Virus: 
1.  LCMV  1,000 
2.  LCMV  500 
1.  LCMV (PEC)~  424 
2.  LCMV (PEC)  105 
ii) Challenge with One Subsequent Heterologous Virus: 
1.  LCMV  1,000 
3.  LCMV  658 
4.  LCMV  185 
1.  LCMV  1,000 
1.  LCMV + PV  467 
4.  LCMV+PV  126 
3.  LCMV+PV  265 
1.  LCMV+PV+VV  256 
4.  LCMV+PV+W  78 
iii) Challenge with Two Subsequent Heterologous Viruses: 
1.  LCMV  1,000 
5.  LCMV  806 
4.  LCMV  185 
3.  LCMV  658 
4.  LCMV + PV  126 
1.  LCMV+PV  467 
iv) Challenge with Three Subsequent Heterologous Viruses: 
1.  LCMV  1,000 
4.  LCMV  185 
v) Rechallenge with LCMV after Multiple Sequential Heterologous Viruses: 
3.  LCMV+PV+MCMV  42 
5.  LCMV + PV + VV  305 
l.  LCMV+PV+VV  256 
LCMV+LCMV  4,545  4.51" 
LCMV + LCMV  3,125  6.2"1" 
LCMV+LCMV  (PEC)  5,000  11.71" 
LCMV+LCMV (PEC)  6,250  59.01" 
LCMV+PV  467  2.0,~ 
LCMV+PV  265  2.55 
LCMV+PV  126  1.55 
LCMV+MCMV  410  2.45 
LCMV+PV+VV  256  1.85 
LCMV+PV+VV  78  1.65 
LCMV+PV+MCMV  42  6.35 
LCMV+PV+VV+MCMV  242  1.1,1, 
LCMV+PV+VV+MCMV  52  1.55 
LCMV+PV+VV  256  4.0,1, 
LCMV+PV+VV  305  2.6,1, 
LCMV+PV+VV  78  2.4,1, 
LCMV+PV+MCMV  42  16.0,1, 
LCMV+PV+VV+MCMV  52  2.4-1, 
LCMV+PV+VV+MCMV  242  1.9,1, 
LCMV + PV + VV + MCMV 
LCMV+PV+W+MCMV 
242  4.1,1, 
52  3.65 
LCMV+PV+MCMV+LCMV  388  8.8"I" 
LCMV+PV+VV+LCMV  1,315  4.31" 
LCMV+PV+VV+LCMV  273  1.11" 
*  Quantification by LDA was made of LCMV-specific, splenic pCTL/50,0000 CD8 + T cells in C57BL/6 mice. These mice were immunized with a 
sublethal acute infection of one virus; the T cell response was allowed to rise and return to homeostasis  (>6 wk), and then a second heterologous vi- 
res was given, followed by a third, and fourth,  allowing each time for a return to homeostasis before giving the next virus or testing for p/f. This p/f  was 
compared with an age-matched control mouse that in that same time period had only received the initial virus or other prior viruses. Each pair of vi- 
rus-specific pCTL/50,000 CD8 + splenic T cells for the control versus test comparison sequence of homologous or heterologous virus(es) was set up 
with the same experiment in the same single LDA. The fold change quantifies either the fold increase or decrease in pCTL comparing the test to the 
control sequence. 
*Experiment number indicates  the various  sequences  of viruses that were assessed during one single  experimental LDA set up whether assessing 
LCMV- (Table 2), PV- (Table 3), or VV-specific  (Table 4) pCTL. 
~Groups followed by (PEC)  represent  data for pCTL/50,000 CD8 + T cells present  in peritoneal exudate instead of splenic T cells. 
Similar  but  more  pronounced  reductions  in  p/f  were 
seen when PV-specific CTL were examined (Table 3). Be- 
cause the design of the experiments with PV frequently used 
mice previously infected with LCMV,  we first determined 
whether  a  prior  LCMV  infection  significantly  altered  the 
p/f to PV.  The PV-specific p/f was similar whether or not 
mice had  previously been infected with LCMV  (Fig.  2  B; 
Table 3  i).  In most of these experiments the control for as- 
sessing PV-specific p/f was a mouse that had in the past re- 
ceived  LCMV  (i.e.,  LCMV+PV).  The  same  individual 
mouse was  used to derive the PV- and LCMV-,  as well as 
the W-specific  pCTL  in multiple compartments.  We  feel 
this  experimental  strategy  strengthens  the  significance  of 
the observation,  as we were able to demonstrate within one 
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PV-specific pCTL/50,000 CD8 + T  cells  ~ 
Exp3  t  Control  Test  Fold change 
(i) Prior infection with LCMV: 
1.  PV  187  LCMV+PV  255  1.41" 
3.  PV  794  LCMV+PV  833  1.05"1" 
6.  PV  83  LCMV + PV  119  1.4'I" 
(ii) Challenge with One Subsequent Heterologous Virus: 
1.  LCMV+ PV  255  LCMV + PV + VV  147  1.7-1, 
4.  PV~  816  LCMV+PV+VV  108  8,1, 
7.  LCMV+PV  1,923  LCMV+PV+VV  342  5.6,1, 
1.  LCMV + PV  255  LCMV + PV + MCMV  39  6.5,1, 
3.  LCMV+PV  833  LCMV+PV+MCMV  189  4.45 
4.  LCMV + PV +W  108  LCMV + PV + VV + MCMV  34  3.2,1, 
(iii) Challenge with Two Subsequent Hetero|ogous Viruses: 
4.  LCMV+PV  816  LCMV + PV +VV+ MCMV  34  24,1, 
"Quantification by LDA was made of PV-specific,  splenic pCTL/50,0000 CD8 + T cells in C57BL/6 mice. These mice were immunized with a 
sublethal acute infection of one virus, the T cell response was allowed to rise and return to homeostasis (>6 wk), and then a second heterologous  vi- 
res was given, followed by a third, and a fourth, allowing each time for a return to homeostasis before giving the next virus or testing for p/f. This p/f 
was compared with an age-matched control mouse that in that same time period had only received the initial virus or other prior viruses. Each pair 
of virus-specific pCTL/50,000 CD8 + splenic T cells for the control versus test comparison sequence of homologous or heterologous  viruses(es) was 
set up within the same experiment in the same single LDA. The fold change quantifies either the fold increase or decrease in pCTL, comparing the 
test to the control sequence. 
~Experiment number indicates  the various sequences  of viruses that were assessed during one single experimental  LDA set up whether assessing 
LCMV- (Table 2), PV- (Table 3), or W-specific (Table 4) pCTL. 
~As PV and LCMV+PV controls have similar p/f and an age-matched LCMV+ PV infected mouse was not available for this experiment, a mouse 
infected with PV alone was used. 
mouse  simultaneously  a  reduction  in  memory  pCTL  to 
two or three different viruses within different organs. There 
was a 5.2-fold (+  1.7; n  =  3) drop in PV-specific pCTL af- 
ter subsequent VV infections and a  5.5-fold  (-  1;  n  =  2) 
drop  after  subsequent  MCMV  infections  (Table  3  ii).  In 
one experiment after infection with two subsequent viruses 
(VV+MCMV)  there was a 24-fold drop  (Table 3  iii). Sim- 
ilarly, infection with heterologous  viruses caused a  reduc- 
tion in Vv-specific  p/f (Table  4).  Examination of all the 
virus combinations tested showed that one subsequent het- 
erologous virus infection decreased spleen p/f 3.0 -+ 0.4-fold 
(n =  16), and two subsequent infections decreased it 8.4 +- 
3-fold (n  =  8)  (Tables 2-4).  The percent reduction by ei- 
ther one or two virus infections was significant (P <0.0005) 
as analyzed by the one-sample t test. 
Simultaneous  Decrease of Memory pCTL in Multiple  T  Ceil 
Compartments.  The above  data from Tables 2--4 focussed 
on pCTL in the spleen, but this deletion of LCMV-  (Fig. 3 
A) and PV-specific (Fig. 3  B) memory pCTL after heterol- 
ogous  virus infections was  a  global  event occurring in all 
lymphoid compartments tested, including the spleen (Fig. 3), 
LNs (Fig. 3, A  and B, Exp.  1 and 2), peritoneal cells (Fig. 3, 
A  and  B,  Exp.  3  and  4),  and peripheral blood  (Fig.  3  A, 
Exp.  2). This suggests that the memory cells were not traf- 
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ticking to a location where they were protected from dele- 
tion,  though  it remains possible that  they became seques- 
tered in a tissue that was not examined. 
Homeostasis of the Lymphoid System.  By 6  wk after each 
vires infection, homeostasis in lymphoid number occurred. 
In the  experiments described here,  the numbers of spleen 
leukocytes after two or more infections (1.2  X  108  +  0.04 
SEM;  n  =  25) were no greater than after one infection (1.2 
￿  108  •  0.08; n  =  14). The same was true of the numbers 
of LN cells (2.2  ￿  106  --- 0.22; n  =  12 vs. 2.1  ￿  106  +  0.19; 
n  =  10),  and PECs  (1.6  ￿  106  +  0.17;  n  =  13 vs.  1.3  X 
106 --- 0.15; n  =  5). 
The percentage ofCD8 + spleen cells did not vary signif- 
icantly between experiments, nor did it significantly change 
over 6me with increasing numbers of viral infections: LGMV 
immune  (CD8 §  cells,  13%  +  0.6,  n  =  3);  PV  immune 
(10% •  0.6, n  =  3); LCMV+PV  immune (11% ~  0.3, n  = 
3);  and  LCMV+PV+VV  immune  (15%  -  0.7,  n  =  3); 
and  LCMV+PV+W+MCMV  (14%,  n  -=  1).  The  per- 
centage  of LN  CD8 +  cells  did  not  significantly vary  be- 
tween individual mice and was independent of virus treat- 
ment (32% +  1.0, n  -= 8). Because there was no significant 
change  in  the  total  number  in  CD8 +  splenocytes  and 
lymph node cells, the reductions in p/f per CD8 cell in the Table 4. Reduaion in  VV-specific pCTL/50,O00  CD8 + T  Cells after Heterologous Virus Infections 
W-specific pCTL/50,000 CD8 + T cells* 
Exp. No.*  Control  Test  Fold change 
i) Prior Infection with LCMV and PV: 
5.  VV  77  LCMV+PV+VV 
ii) Challenge with One Subsequent Heterologous Vires: 
8.  VV  42  VV+MCMV 
iii) Challenge with One Subsequent Heterologous Virus and Rechallenge with LCMV: 
5.  LCMV+PV+VV  44  LCMV+PV+VV+MCMV+LCMV 
iv) Challenge with Two Subsequent Heterologous Viruses: 
8.~  VV  42  LCMV+PV+VV+MCMV+VSV 
44  1.8,], 
15  2.8,1, 
17  2.6.1, 
3  14,1, 
*Quantification by LDA was made of W-specific, splenic pCTL/50,0000 CD8 + T cells in C57BL/6  mice. These mice were immunized with a 
sublethal acute infection of one virus, the T cell response was allowed to rise and return to homeostasis (>6 wk), and then a second heterologous virus 
was given, followed by a third, fourth, and fifth, allowing each time for a return to homeostasis before giving the next virus or testing for p/f. This 
p/f was compared with an age-matched control mouse that in that same time period had only received the initial virus or other prior viruses. Each 
pair of virus-specific pCTL/50,000 CD8 + splenic T cells for the control versus test comparison sequence of homologous or heterologous virus(es) 
was set up within the same experiment in the same single LDA. The fold change quantifies either the fold increase or decrease in pCTL comparing 
the test to the control sequence. 
*Experiment number indicates the various sequences of viruses that were assessed during one single experimental LDA set up whether  assessing 
LCMV- (Table 2), PV- (Table 3), or VV-specific (Table 4) pCTL. 
~As VV and LCMV + PV+ VV controls have p/f within twofold of each other and an age-matched LCMV + PV +VV infected mouse was not avail- 
able for this experiment, a mouse infected with VV alone was used. 
immune  mice  directly correlate with  the  total number  of 
pCTL.  However,  the  percentage  of CD8 +  PECs,  which 
represent  only a  small number  of cells in  comparison  to 
splenocytes  or  LN  cells,  was  significantly different  (P  = 
0.017,  Student's  t  test)  between  mice  that  had  received 
only one virus (18%  +  3,  n  =  5) versus those that received 
two or more (30%  +  3, n  =  11). 
Discussion 
Our recent studies have indicated that immune responses 
to viruses are not mounted in isolation by exclusively naive 
cells of the  immune  system  (12-1.~,  17),  Instead,  the  im- 
mune  response to one virus can predispose a host to make 
an  altered imnmno  response  when  encountering a  second 
unrelated  virus.  This  altered immune  response  consists, at 
least in  part,  of stimulated  memory  T  cells cross-reactive 
between  two  heterologous  viruses.  This  is  not  surprising 
because T  cells recognize short peptides, and in vitro stud- 
ies  with  defined T  cell clones  have  shown  that  the  same 
clone  may  recognize  distinct peptides with  very  different 
amino acid lequences (30~33).  Gwen the polyclonal nature 
of the CTL r~ponsr  to viral infections, there ~ppears to be 
sufficient  diversi~y within  the  memo~  pCTL  repertoire 
specific for one  virus to render some clones susceptible to 
reactivation  by  apparently  unrelated  heteroAogous viruses, 
We have shown  that this reactivation of memory cedis can 
prospectively prime the immune response to the second vi- 
rus (,t5), and it may contribute either to enhanced protec- 
tive  imnmnity  (17,  and  our  unpublished  data)  or  to  en- 
hanced immunopathology (18,  and our unpublished data). 
In the present study we show that the immune response to 
one  virus not only has prospective but also has  retrospec- 
tive effects on the memory responses specific for viruses to 
which  the host had been previously exposed. These retro- 
spective effects in the systems studied invariably involved a 
significant reduction in pCTL specific for pathogens from 
previous infections. 
In the first part of this study detailed analyses of the fre- 
quencies and specificities of the CTL  responses during the 
progression  of the  acute  to  the  memory  response  led  to 
several surprising results. Examination of the virus-specific 
p/f per CD8 +  T  cell showed  that,  even  though  the  total 
splenocyte and total CI)bP'  T  cell number declined dramat- 
ically at the conclusion of the acute infection, there was only 
a  two-  to  fourfold  decrease  m  p/f per  CD8 +  T  cell  be- 
tween tl~e acutely infected and immune  mice for the three 
viruses tested (LCMV,  PV, and VV). The p/f per C'D8 + T 
cells, about  1:50  for  /CMV,  thus  remained  at  very  high 
levels for the lifetime of the animals. Considering that not all 
LCMV-specific CD8 ~ T  cells would be cytotoxic precur- 
sors and  that  the  efficiency of the  LDA  must  be  <100%, 
these results would indicate that a  history of a  viral infec- 
tion  must  significantly alter the  immunological repertoire 
available to combat other infections. The finding that mice 
given  a  second  LCMV  infection  will  maintain  a  p/f of 
"-,1:11  (Table 2)  further  illustrates the point that  a  signifi- 
cam population of the T  cells in a host can be specific to a 
pathogen  long after the  acute  infection has resolved. R.e- 
ports of nmre dramatic declines m  virus-specific p/f at the 
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ther (a) reporting the frequencies as per spleen or per sple- 
nocyte, rather than per CD8 + T  cell (1);  (b) the use of very 
high doses of LCMV strains (clone  13  or Docile)  that can 
disseminate  and  cause  an  apoptotic  clonal  exhaustion  of 
CTL (34);  or (c) suboptimal LDA techniques inadequate to 
efficiently stimulate memory cells, which are at a lower ac- 
tivation state than the CTL present during the acute infec- 
tion. 
The  immunodominant  peptide  specificities  relative  to 
the total LCMV-specific CTL response also did not change 
between day 8 of the acute infection and the immune state. 
This indicates that when the apoptotic events causing a re- 
duction of the total CD8 + T  cell number at the end of the 
acute infection occurred,  there was no further selection of 
T  cells based on their target specificity. This would be con- 
sistent  with  the  observation  that  most  LCMV  antigen  is 
gone by day 8. In contrast, in models of high dose infection 
with  disseminating LCMV  infection,  where  high  antigen 
load is present at day 8,  there is a selective elimination  of 
virus-specific CTL and pCTL (34).  We believe that these 
events demonstrate two contrasting mechanisms ofapopto- 
sis in these infections, one which is antigen dependent and 
occurs in the presence of excess antigen, and the other, de- 
scribed by us here and elsewhere (7, 8,  11,  12),  that repre- 
sents  an  antigen-independent  across-the-board  decline  in 
CD8 + T  cell number after most of the antigen has cleared 
and  without  a  selective  exhaustion  of antigen-specific  T 
cells.  Selection for immunodominant peptide specificity in 
the  LCMV  system  must  therefore  take  place  in  earlier 
stages of infection, before day 8 and the ensuing apoptotic 
events. 
The impressive homeostasis in the memory CTL pool is 
disrupted when heterologous viruses are introduced, as these 
heterologous infections first activate (14,  15,  35) and then, 
as shown  here,  induce  a reduction  in the  memory pCTL 
pool to earlier viruses.  The mechanism for this  decline in 
CTL p/f is as yet not known. A dilution ofpCTL number 
to an earlier virus may occur after a selective expansion of 
pCTL specific to the  second virus and  the  ensuing apop- 
totic downregulation and return to homeostasis thereafter. 
The explanation for this  decline  in pCTL may, however, 
be more complex, as suggested by our previous observation 
that heterologous viruses can stimulate expansion of mem- 
ory T  cells cross-reactive with earlier viruses (15). The con- 
sequences  of this  could be  that  there  would be not  only 
quantitative but also  qualitative changes in CTL memory. 
Preliminary  data  supporting  this  supposition  demonstrate 
that  the  ratio  of the  three  immunodominant  peptides  to 
LCMV-specific pCTL, which  is normally unchanged  be- 
tween days 7  and 8  and long-term memory, is altered by 
heterologous viral infections (Selin, L.K. and R.M. Welsh, 
unpublished  data).  In addition,  within  the same mice im- 
mune  to  both  LCMV  and  PV,  subsequent  infections  re- 
duced  PV-specific  p/f more  efficiently than  LCMV-spe- 
cific  p/f,  arguing  for  some  selectivity  in  pCTL  deletion 
(Tables 2  and 3). A  change in the qualitative specificity of 
the T  cell repertoire reactive with viruses from previous in- 
fections would be consistent with the hypothesis that cross- 
reactive T  cell responses are important determinants modi- 
fying this memory cell loss.  A  decrease in pCTL memory 
may also be influenced by viral replication within and sub- 
sequent lysis of memory lymphocytes activated in response 
to a heterologous virus infection.  All of the viruses tested 
are capable of some, though usually limited, replication in 
lymphocyte  populations,  and  activated  lymphocytes  are 
better hosts  for viral replication  than  are resting lympho- 
cytes (36). 
Factors  contributing  to  the  maintenance  of memory 
CTL  remain  unclear,  and  opinions  differ  regarding  the 
need  for  persisting  antigen  to  sustain  this  highly  stable 
memory response when there is no interference with other 
infections. We did not address the question of antigen per- 
sistence maintaining memory, but none of these viruses es- 
tablish  detectable persistent  infections  under  these  condi- 
tions  (1,  18,  28),  suggesting  that  replicating viral antigen 
may not be needed to drive memory. Our present data do 
not, however, negate the theory that cross-reactivity could 
play a role in maintaining memory cells.  It is possible that 
either self or even foreign antigens presented  during per- 
haps a different type of immunological milieu (e.g., a lower 
intensity immune response with an altered cytokine bath, 
in contrast to that in these potent virus infections) can acti- 
vate memory cells in a cross-reactive manner but not result 
in their deletion. 
Because  the  natural  host  would  have many viral infec- 
tions  throughout  a lifetime,  and because p/f can be very 
high after each new infection (as high as 1/11 CD8 + T  cells 
after two infections with LCMV; Table 2 v), it would not 
be possible to maintain lymphoid homeostasis ifpCTL spe- 
cific for previous infections did not decline  as new infec- 
tions occurred. It is not known to what level the CTL p/f 
has  to  fall  before memory responses  are  compromised to 
biologically significant levels, but a meaningful depletion in 
T  cell memory would seem likely after a lifetime of infec- 
tions, unless the host is continually reexposed to the origi- 
nal immunizing antigen or to other antigens that stimulate 
cross-reactive  T  cells  (1-4,  15,  37-39).  The  results  pre- 
sented here and elsewhere thus indicate that viral infections 
do not occur in immunological isolation, that the immune 
response to each infection is influenced by prior exposures 
to  other antigens,  and that  each new infection affects the 
previous T  cell memory pool. This type of continual mod- 
ulation  of CD8 +  T  cell  responses  may have  a  significant 
positive or negative impact on an individual's ability to re- 
spond to an infectious agent. 
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